Taurine 5 pp 537-545 | Cite as

Taurine in Aging and Models of Neurodegeneration

  • Ralph DawsonJr.
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 526)


Taurine, the second most abundant amino acid in the CNS, is acknowledged to be important in cell volume regulation yet little is known about how aging might alter taurine homeostasis. Unfortunately, few investigators have focused on the study of taurine in aging and senescence. Previously we summarized much of the older work showing that taurine content declines in a number of tissues with advanced age in rodents1. I will briefly summarize some recent studies that have examined the effects of aging on taurine. I will also summarize our own findings that point to several potential mechanisms that may impact taurine homeostasis with advanced aging.


Ozone Treatment Taurine Supplementation Taurine Transporter Advanced Aging Taurine Release 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Dawson, R., Eppler, B., Patterson, T.A., Shih, D., and Liu, S., 1996, The Effects of Taurine in a Rodent Model of Aging. In Taurine 2: Basic and Clinical Aspects, (R. Huxtable, J. Azuma, Nakagawa, K. Kuriyama, and A. Baba, eds.), Plenum, New York, pp. 37–50.Google Scholar
  2. 2.
    Del Arco, A., Segovia, G., Prieto, L., and Mora, F., 2001, Endogenous glutamate-taurine interaction in striatum and nucleus accumbens of the freely moving rat: studies druing the normal process of aging. Mech. Ageing Dev. 122: 401–414.CrossRefGoogle Scholar
  3. 3.
    Saransaari, P. and Oja, S.S., 1997, Taurine release from the developing and ageing hippocampus: stimulation by agonist of inotropic glutamate receptors. Mech. Ageing Dev. 99: 219–232.CrossRefGoogle Scholar
  4. 4.
    Dawson, R., Pelleymounter, M.A., Cullen, M.J., Gollub, M. and Liu, S., 1999, An age-related decline in striatal taurine is correlated with a loss of dopaminergic markers. Brain Res. Bull. 48: 319–324.Google Scholar
  5. 5.
    Rivas-Arancibia, S., Dorado-Martinez, C., Borgonio-Perez, G., Hiriart-Urdanivia, M., Verdugo-Diaz, L., Duran-Vazquez, A., Colin-Baranque, L., and Avila-Costa, M.R., 2000, Effects of taurine on ozone-induced memory deficits and lipid peroxidation levels in brains of young, mature, and old rats. Environ. Res. 82: 7–17.Google Scholar
  6. 6.
    Eppler, B. and Dawson, R., 2001, Dietary taurine manipulations in aged male Fischer 344 rat tissue: taurine concentration, taurine biosynthesis, and oxidative markers. Biochem. Pharmacol. 62: 29–39.CrossRefGoogle Scholar
  7. 7.
    Esquifino, A.L, Garcia Bonacho, M., Arce. A., Cutrera, R.A., and Cardinali, D.P., 2001, Age-dependent changes in 24-hour rhythms of thymic and circulating growth hormone and adrenocorticotrophin in rats injected with Freund’s adjuvant. Neuroimmunomodulation, 9: 237–246.PubMedCrossRefGoogle Scholar
  8. 8.
    Iglesias-De La Cruz, C., Ruiz-Torres, P., Garcia Del Moral, R., Rodriguez-Puyol, M., and Rodriguez-Puyol, D., 2000, Age-related progressive renal fibrosis in rats with ACE inhibitors and taurine. Am. J. Physiol. 278: F122–F129.Google Scholar
  9. 9.
    Kishida, T., Akazawa, T., and Ebihara, K., 2001, Influence of age and ovariectomy on the hypocholesterolemic effects of dietary taurine in rats fed a cholesterol-free diet. Nutri. Res. 21: 1025–1033.Google Scholar
  10. 10.
    Dawson, R., Liu, S., Eppler, B., and Patterson, T., 1999, Effects of dietary taurine supplementation or deprivation in aged male Fischer 344 rats. Mech. Ageing Dey. 107: 73–91.CrossRefGoogle Scholar
  11. 11.
    Heller-Stilb, B., van Roeyen C., Rascher, K., Hartwig, H-G., Huth, A. Seeliger, M.W., Warskulat, U. and Häussinger, D., 2001, Disruption of the taurine transporter gene (taut) leads to retinal degeneration in mice FASEB J. express article 10.1096/fj.010691fje. Published online December 28, 2001.Google Scholar
  12. 12.
    Piemo, S., De Luca, A., Camerino, C., Huxtable, R.J., and Conte Camerino, D., 1998, Chronic administration of taurine to aged rats improves the electrical and contractile properties of skeletal muscle fibers. J. Pharmacol. Exp. Therapeut. 286: 1183–1190.Google Scholar
  13. 13.
    Massie, H.R., Williams, T.R. and DeWolfe, L.K., 1989, Changes in taurine in aging fruit flies and mice. Exp. Gerontol. 24: 57–65.CrossRefGoogle Scholar
  14. 14.
    Eppler, B. and Dawson, R., 1998, The effects of aging on taurine content and biosynthesis in different strains of rats. In: Taurine 3. Cellular and Regulatory Mechanisms (S. Schaffer, J.B. Lombardini, and R.J. Huxtable eds), Plenum Press, New York, pp.55–61.Google Scholar
  15. 15.
    Airaksinen, E.M., Paljarvi, L., Partanen, J., Collan, Y., Laakso, R. and Pentikainen, T., 1990, Taurine in normal and diseased human skeletal muscle. Acta Neurol. Scand. 81: I7.Google Scholar
  16. 16.
    Corman, B., Pratz, J., and Poujeol, P., 1985, Changes in anatomy, glomerular filtration, and solute excretion in aging rat kidney. Am J. Physiol. 248: R282–R287.PubMedGoogle Scholar
  17. 17.
    Eppler, B. and Dawson, R. 1999, Cysteine sulfinic acid decarboxylase and cysteine dioxygenase activities do not correlate with strain-specific changes in hepatic and cerebellar taurine content in aged rats. Mech. Aging Dey. 110: 57–72.CrossRefGoogle Scholar
  18. 18.
    Beetsch, J.W. and Olson, J.E., 1998, Taurine synthesis and cysteine metabolism in cultured rat astrocytes: effects of hyperosmotic exposure. Am. J. Physiol. 274: C866–C874.PubMedGoogle Scholar
  19. 19.
    Liu, R-M. and Choi, J., 2000, Age-associated decline in y-glutamylcysteine synthetase gene expression in rats. Free Rad. Biol. Med. 28: 566–574.Google Scholar
  20. 20.
    Bakhtian, S., Kimura, R.E. and Galinksy, R.E., 1993, Age-related changes in homeostasis of inorganic sulfate in male F-344 rats. Mech. Aging Dey. 66: 257–267.CrossRefGoogle Scholar
  21. 21.
    Timbrell, J.A., Seabra, V., and Waterfield, C.J., 1995, The in vivo and in vitro protective properties of taurine. Gen. Pharmac. 26: 453–462.Google Scholar
  22. 22.
    Redmond, H.P., Stapleton, P.P., Neary, P., and Bouchier-Hayes, D., 1998, Immunonutrition: the role of taurine. Nutrition 14: 599–604.PubMedCrossRefGoogle Scholar
  23. 23.
    Biasetti, M. and Dawson, R., 2002, Effects of sulfur containing amino acids on iron and nitric oxide stimulated catecholamine oxidation. Amino Acids 22: 351–368.PubMedCrossRefGoogle Scholar
  24. 24.
    Reynolds, W.F., Rhees, J., Maciejewski, D., Paladino, T., Sieburg, H., Maki, R.A., and Masliah, E., 1999, Myeloperoxidasea polymorphism is associated with gender specific risk for Alzheimer’s disease. Exp. Neurol. 155: 31–41.Google Scholar
  25. 25.
    Kearns, S. and Dawson, R., 2000, Cytoprotective effect of taurine against HOCI toxicity to PC12 cells. In: Taurine 4. Taurine and Excitable Tissues_ (L. Della Corte, R.J. Huxtable, G. Sgaragli and K.F. Tipton eds.) Plenum Press, New York, pp. 563–570.Google Scholar

Copyright information

© Springer Science+Business Media New York 2003

Authors and Affiliations

  • Ralph DawsonJr.
    • 1
  1. 1.Department of PharmacodynamicsCollege of Pharmacy, University of FloridaGainesvilleUSA

Personalised recommendations